查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828137

2025年全球内部神经调节设备市场报告

Internal Neuromodulation Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体内神经调节设备的市场规模呈现强劲成长势头，从2024年的25.9亿美元增至2025年的27.5亿美元，复合年增长率为6.0%。预测期内的成长可归因于慢性疼痛管理、人口老化、临床研究和测试、神经系统疾病的流行以及患者的认知和接受度。

预计未来几年，内部神经调节设备市场规模将强劲成长，2029年将达到38.7亿美元，复合年增长率为8.9%。预测期内的成长可归因于个人化医疗趋势、医疗保健支出的增加、合作研究与伙伴关係关係、患者治疗效果和真实世界证据以及监管格局的变化。预测期内的主要趋势包括微型化和可用技术、无线连接和远端监控、神经调节应用的不断扩展、用于精确调节的闭合迴路系统以及对以患者为中心的设计的关注。

内部神经调节装置是一类透过手术植入体内的医疗设备，为神经系统的特定部位提供电刺激，以缓解各种神经和精神症状。

体内神经调节装置的主要类型包括脊髓刺激设备、深层脑部刺激器、荐骨神经刺激器、迷走神经刺激设备和胃神经刺激设备。这些装置采用多种技术，包括体内和体外神经调节，以及金属生物材料、聚合物生物材料和陶瓷生物材料等生物材料。这些装置用于治疗腰椎手术失败症候群、帕金森氏症、尿失禁、癫痫和胃轻瘫等疾病。这些装置的最终用户包括医院、诊所、家庭医疗保健和社区医疗保健。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供内部神经调节剂市场统计数据，例如全球市场规模、区域份额、内部神经调节剂市场份额的竞争对手、详细的内部神经调节剂细分市场、市场趋势和商业机会，以及在内部神经调节剂行业取得成功所需的数据。本内部神经调节剂市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

我们预测未来五年该市场将成长8.9%，较先前预测略有下降0.3%。下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接波及美国，导致可充电神经刺激设备电池和定向导线阵列的供应链中断，这些产品主要来自英国和加拿大等主要地区，这可能导致慢性疼痛治疗​​的延迟和神经系统治疗成本的增加。此外，由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，这种影响也将更加广泛地蔓延。

神经系统疾病盛行率的上升预计将推动体内神经调节设备市场的成长。神经系统疾病涵盖多种影响神经系统的疾病，包括大脑、脊髓和周边神经。体内神经调节设备透过向神经系统的特定部位施加定向电刺激来治疗神经系统和精神疾病，以缓解慢性疼痛、运动障碍和情绪障碍等症状。透过减轻症状，这些设备可以改善患者的生活品质，并促进日常活动的进行。例如，2023年4月，美国生物医学图书馆国家医学图书馆报告称，670万美国患有阿兹海默症，并预测到2060年这一数字将达到1,380万人。此外，2022年5月，英国上议院图书馆报告称，截至2022年1月31日，英格兰共有1638名全职神经病学工作人员，高于2021年的1562名和2020年的1468名。因此，神经系统疾病盛行率的不断上升正在推动内部神经调节设备市场的扩张。

脑肿瘤发生率的上升预计将推动内部神经调节剂市场的扩张。脑肿瘤是一类发生在脑部和脊髓的肿瘤，其复杂性和治疗难度都很大。内部神经调节剂已成为治疗各种脑部疾病的有前景的解决方案，它透过直接向特定脑区传递电刺激或其他形式的能量来调节神经元活动并产生治疗效果。美国脑肿瘤协会报告称，2022年将有约94,390名美国被诊断出患有脑肿瘤，预计2023年将有18,990人死于恶性脑肿瘤。因此，脑肿瘤发生率的上升是内部神经调节剂市场成长的催化剂。

产品创新是内部神经调节设备市场的一个显着趋势。该领域的主要企业正在积极开发新技术以保持其市场地位。例如，2023年3月，总部位于爱尔兰的医疗设备製造商Neuromod Device Ltd.宣布其Lenire系统获得美国食品药物管理局(FDA)的De novo批准。 Lenire系统结合了声音刺激和舌头刺激来治疗耳鸣，这是一种以耳鸣为特征的神经系统疾病。此创新系统采用双管齐下的神经刺激方法：利用蓝牙耳机播放独特的声音来刺激听觉神经，同时Neuromod的Tonguetip设备向舌头表面传递适度的电脉衝。这项技术为耳鼻喉科医生提供了一种创新工具，可以推荐给生活中受到中度至重度耳鸣影响的患者。

为了获得竞争优势，内部神经调节设备市场的主要企业正专注于开创性的技术创新，包括数位健康应用程式。数位健康应用程式旨在为用户在行动装置上提供健康相关服务和资讯的软体应用程式。例如，2022年7月，美国医疗设备供应商雅培实验室推出了Neurosphere Virtual Clinic，这是一项突破性的技术，使配备雅培神经刺激设备的患者能够与医生进行远端沟通。此功能可让患者透过安全的应用程式内视讯聊天和整合的远端编程来确认正确的设定和功能，或接收新的治疗设定。该平台为医生提供有关患者设备使用和疼痛程度的即时数据。

2022年3月，美国医疗器材製造商Electro 医疗设备 Products International (EPI)收购了Pulvinar Neuro，收购金额未揭露。此次收购增强了Pulvinar Neuro的实力，使其能够推进其专利技术，包括经颅交流电刺激(tACS)。此外，此次收购还增强了其针对精神和神经系统疾病的云端数位化治疗以及客製化回馈刺激技术。 Pulvinar Neuro是一家总部位于美国的医疗科技公司，专注于开髮用于治疗神经和精神疾病的深部脑部刺激(DBS)系统。

在内部神经调节设备市场中营运的主要企业包括美敦力公司、波士顿科学公司、BioControl Medical Ltd.、Aleva Neurotherapeutics SA、Bioness Inc.、Uroplasty Inc.、雅培实验室、EnteroMedics Inc.、LivaNova plc、NeuroPace Inc.、Synapse Biomedical Inc.、Soterixave Inc.、Neurox Medical、Neurot、St团Incorporated、SPR Therapeutics、Axonics Modulation Technologies Inc.、Saluda Medical Pty Limited、MicroTransponder Inc.、EndoStim Inc.、NeuroMetrix Inc.、Second Sight Medical Products Inc.、Neurotech International Limited、Neuronix Ltd. 和 Neuronoff Inc.

2024年，北美将成为体内神经调节设备市场最大的地区。根据全球体内神经调节设备市场报告，预计亚太地区将成为预测期内成长最快的地区。体内神经调节设备市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

内部神经调节设备市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

内部神经调节设备市场包括电极、导线、接收器和其他产品的销售。该市场的价值指的是“出厂价”，即产品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球内部神经调节器：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球内部神经调节设备市场：成长率分析
  • 全球内部神经调节设备市场表现：规模与成长，2019-2024
  • 全球内部神经调节设备市场预测：规模与成长，2024-2029，2034
  • 全球内部神经调节剂：总目标市场（TAM）

第六章 市场细分

  • 全球内部神经调节设备市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 脊髓刺激设备
  • 深层脑部刺激器
  • 荐骨神经刺激器
  • 迷走神经刺激设备
  • 胃神经刺激设备
  • 全球内部神经调节设备市场（按技术类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 内部神经调节
  • 外部神经调节
  • 全球内部神经调节设备市场（按生物材料、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 金属生物材料
  • 聚合物生物材料
  • 陶瓷生物材料
  • 全球内部神经调节设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 背部手术失败综合症
  • 帕金森氏症
  • 尿失禁
  • 癫痫
  • 胃轻瘫
  • 全球内部神经调节设备市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 家庭医疗保健
  • 社区医疗保健
  • 全球内部神经调节设备市场：脊髓刺激设备细分市场，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 常规脊髓刺激设备
  • 可充电脊髓刺激设备
  • 非充电脊髓刺激设备
  • 全球内部神经调节设备市场：深层脑部刺激器细分，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 单导程深层脑部刺激器
  • 双导联深部脑部刺激器
  • 自适应深层脑部刺激器
  • 全球内部神经调节设备市场：荐骨神经刺激器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 植入式荐骨神经刺激器
  • 外部荐骨神经刺激器
  • 全球内部神经调节设备市场：迷走神经刺激设备细分市场，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 植入式迷走神经刺激设备
  • 经皮迷走神经刺激设备
  • 全球内部神经调节设备市场：胃神经刺激设备细分市场，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 植入式胃神经刺激设备
  • 外部胃神经刺激设备

第七章 区域和国家分析

  • 全球内部神经调节设备市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球内部神经调节设备市场：国家、绩效与预测，2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 内部神经调节设备市场：竞争格局
  • 内部神经调节设备市场：公司简介
    • Medtronic plc
    • Boston Scientific Corporation
    • BioControl Medical Ltd.
    • Aleva Neurotherapeutics SA
    • Bioness Inc.

第31章：其他领先和创新企业

  • Uroplasty Inc.
  • Abbott Laboratories
  • EnteroMedics Inc.
  • LivaNova plc
  • NeuroPace Inc.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc.
  • Neuros Medical Inc.
  • Nevro Corp.
  • Nuvectra Corporation
  • Stimwave Technologies Incorporated
  • SPR Therapeutics
  • Axonics Modulation Technologies Inc.
  • Saluda Medical Pty Limited
  • MicroTransponder Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年内部神经调节设备市场：提供新机会的国家
  • 2029年内部神经调节设备市场：细分市场带来新机会
  • 2029年内部神经调节设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24244u

Internal neuromodulation devices are a category of medical devices that are surgically implanted inside the body to deliver electrical stimulation to specific areas of the nervous system, offering relief for various neurological and psychiatric conditions.

The primary types of internal neuromodulation devices include spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric neurostimulators. These devices utilize different technologies, encompassing both internal and external neuromodulation, along with biomaterials such as metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. They find applications in treating conditions such as failed back surgery syndrome, Parkinson's disease, urinary incontinence, epilepsy, and gastroparesis. The end-users of these devices span hospitals, clinics, home healthcare, and community healthcare.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The internal neuromodulation devices market research report is one of a series of new reports from The Business Research Company that provides internal neuromodulation devices market statistics, including internal neuromodulation devices industry global market size, regional shares, competitors with a internal neuromodulation devices market share, detailed internal neuromodulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the internal neuromodulation devices industry. This internal neuromodulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The internal neuromodulation devices market size has grown strongly in recent years. It will grow from $2.59 billion in 2024 to $2.75 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to chronic pain management, aging population, clinical research and trials, neurological disorders prevalence, patient awareness and acceptance.

The internal neuromodulation devices market size is expected to see strong growth in the next few years. It will grow to $3.87 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to personalized medicine trends, rising healthcare expenditure, collaborations and partnerships, patient outcomes and real-world evidence, regulatory landscape changes. Major trends in the forecast period include miniaturization and implantable technology, wireless connectivity and remote monitoring, expanded applications for neuromodulation, closed-loop systems for precise modulation, focus on patient-centric design.

The forecast of 8.9% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for rechargeable neurostimulator batteries and directional lead arrays, sourced from key regions such as the UK and Canada, which could lead to delayed chronic pain treatments and increased costs for neurological therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of neurological diseases is anticipated to drive growth in the internal neuromodulation devices market. Neurological diseases encompass a wide range of disorders that impact the nervous system, including the brain, spinal cord, and peripheral nerves. Internal neuromodulation devices are used to treat neurological and psychiatric conditions by delivering targeted electrical stimulation to specific parts of the nervous system, helping to alleviate symptoms like chronic pain, movement disorders, and mood disorders. These devices can enhance patients' quality of life by reducing symptoms, making it easier for them to carry out daily tasks. For example, in April 2023, the National Library of Medicine, a U.S.-based biomedical library, reported that 6.7 million Americans are living with Alzheimer's, a number projected to reach 13.8 million by 2060. Additionally, in May 2022, the House of Lords Library in the UK reported that as of January 31, 2022, there were 1,638 full-time equivalent staff in England's neurology workforce, up from 1,562 in 2021 and 1,468 in 2020. Consequently, the increasing prevalence of neurological diseases is fueling the expansion of the internal neuromodulation devices market.

The rising incidence of brain cancers is anticipated to fuel the expansion of the internal neuromodulation devices market. Brain cancer, a diverse group of tumors originating in the brain or spinal cord, poses complex challenges for understanding and treatment. Internal neuromodulation devices emerge as a promising therapeutic solution for various brain disorders, delivering electrical stimulation or other forms of energy directly to specific brain regions to modulate neuronal activity and induce therapeutic effects. In 2022, the National Brain Tumor Society reported an expected diagnosis of brain tumors in approximately 94,390 Americans, with an estimated 18,990 deaths from malignant brain tumors in 2023. Thus, the growing incidence of brain cancers serves as a catalyst for the growth of the internal neuromodulation devices market.

A prominent trend gaining traction in the internal neuromodulation devices market is product innovation. Major companies in this segment are actively engaged in developing new technologies to maintain their market positions. For instance, in March 2023, Ireland-based medical equipment manufacturer Neuromod Device Ltd. announced that its Lenire system had received De Novo clearance from the US Food and Drug Administration (FDA). The Lenire system employs a combination of sound stimulation and tongue stimulation to treat tinnitus, a neurological disorder characterized by ringing in the ears. This innovative system uses a dual-pronged approach to neurostimulation, utilizing Bluetooth headphones to play unique sounds stimulating the auditory nerve, while Neuromod's Tonguetip device transmits moderate electrical stimulation to the tongue's surface. This technology provides otolaryngologists with an innovative tool to recommend to patients experiencing a moderately negative impact on their lives due to tinnitus.

Major companies in the internal neuromodulation devices market are concentrating on developing technological innovations, including digital health apps, to gain a competitive edge. Digital health apps are software applications designed to deliver health-related services and information to users on mobile devices. For example, in July 2022, US-based medical device provider Abbott Laboratories launched the NeuroSphere Virtual Clinic, a groundbreaking technology allowing patients with Abbott's neurostimulation devices to remotely communicate with doctors. This feature enables patients to ensure proper settings, functionality, and receive new treatment settings via secure in-app video chat and integrated remote programming. The platform provides real-time data to physicians about patients' device usage and pain levels.

In March 2022, US-based medical equipment manufacturer Electromedical Products International (EPI) acquired Pulvinar Neuro for an undisclosed amount. Through this acquisition, Pulvinar Neuro gains enhanced capabilities for promoting its patented technologies, such as transcranial alternating current stimulation (tACS). Additionally, the acquisition enhances its cloud-enabled digital treatments for mental and neurological conditions and customized feedback stimulation. Pulvinar Neuro is a US-based medical technology company specializing in deep brain stimulation (DBS) systems for treating neurological and psychiatric disorders.

Major companies operating in the internal neuromodulation devices market include Medtronic plc, Boston Scientific Corporation, BioControl Medical Ltd., Aleva Neurotherapeutics SA, Bioness Inc., Uroplasty Inc., Abbott Laboratories, EnteroMedics Inc., LivaNova plc, NeuroPace Inc., Synapse Biomedical Inc., Soterix Medical Inc., Neuros Medical Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Incorporated, SPR Therapeutics, Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, MicroTransponder Inc., EndoStim Inc., NeuroMetrix Inc., Second Sight Medical Products Inc., Neurotech International Limited, Neuronix Ltd., Neuronoff Inc.

North America was the largest region in the internal neuromodulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the internal neuromodulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The internal neuromodulation devices market consists of sales of electrodes, leads, receivers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Internal Neuromodulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on internal neuromodulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for internal neuromodulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The internal neuromodulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Spinal Cord Stimulator; Deep Brain Stimulator; Sacral Nerve Stimulator; Vagus Nerve Stimulator; Gastric Neuro Stimulator
  • 2) By Technology Type: Internal Neuromodulation; External Neuromodulation
  • 3) By Biomaterial: Metallic Biomaterials; Polymeric Biomaterials; Ceramic Biomaterials
  • 4) By Application: Failed Back Surgery Syndrome; Parkinson's Disease; Urinary Incontinence; Epilepsy; Gastroparesis
  • 5) By End-User: Hospitals; Clinics; Home Healthcare; Community Healthcare
  • Subsegments:
  • 1) By Spinal Cord Stimulator: Traditional Spinal Cord Stimulator; Rechargeable Spinal Cord Stimulator; Non-Rechargeable Spinal Cord Stimulator
  • 2) By Deep Brain Stimulator: Single Lead Deep Brain Stimulator; Dual Lead Deep Brain Stimulator; Adaptive Deep Brain Stimulator
  • 3) By Sacral Nerve Stimulator: Implantable Sacral Nerve Stimulator; External Sacral Nerve Stimulator
  • 4) By Vagus Nerve Stimulator: Implantable Vagus Nerve Stimulator; Transcutaneous Vagus Nerve Stimulator
  • 5) By Gastric Neuro Stimulator: Implantable Gastric Neuro Stimulator; External Gastric Neuro Stimulator
  • Companies Mentioned: Medtronic plc; Boston Scientific Corporation; BioControl Medical Ltd.; Aleva Neurotherapeutics SA; Bioness Inc.; Uroplasty Inc.; Abbott Laboratories; EnteroMedics Inc.; LivaNova plc; NeuroPace Inc.; Synapse Biomedical Inc.; Soterix Medical Inc.; Neuros Medical Inc.; Nevro Corp.; Nuvectra Corporation; Stimwave Technologies Incorporated; SPR Therapeutics; Axonics Modulation Technologies Inc.; Saluda Medical Pty Limited; MicroTransponder Inc.; EndoStim Inc.; NeuroMetrix Inc.; Second Sight Medical Products Inc.; Neurotech International Limited; Neuronix Ltd.; Neuronoff Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Internal Neuromodulation Devices Market Characteristics

3. Internal Neuromodulation Devices Market Trends And Strategies

4. Internal Neuromodulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Internal Neuromodulation Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Internal Neuromodulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Internal Neuromodulation Devices Market Growth Rate Analysis
  • 5.4. Global Internal Neuromodulation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Internal Neuromodulation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Internal Neuromodulation Devices Total Addressable Market (TAM)

6. Internal Neuromodulation Devices Market Segmentation

  • 6.1. Global Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Gastric Neuro Stimulator
  • 6.2. Global Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Internal Neuromodulation
  • External Neuromodulation
  • 6.3. Global Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • 6.4. Global Internal Neuromodulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Failed Back Surgery Syndrome
  • Parkinson's Disease
  • Urinary Incontinence
  • Epilepsy
  • Gastroparesis
  • 6.5. Global Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home Healthcare
  • Community Healthcare
  • 6.6. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Spinal Cord Stimulator
  • Rechargeable Spinal Cord Stimulator
  • Non-Rechargeable Spinal Cord Stimulator
  • 6.7. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Deep Brain Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Lead Deep Brain Stimulator
  • Dual Lead Deep Brain Stimulator
  • Adaptive Deep Brain Stimulator
  • 6.8. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Sacral Nerve Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Sacral Nerve Stimulator
  • External Sacral Nerve Stimulator
  • 6.9. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Vagus Nerve Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Vagus Nerve Stimulator
  • Transcutaneous Vagus Nerve Stimulator
  • 6.10. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Gastric Neuro Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Gastric Neuro Stimulator
  • External Gastric Neuro Stimulator

7. Internal Neuromodulation Devices Market Regional And Country Analysis

  • 7.1. Global Internal Neuromodulation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Internal Neuromodulation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Internal Neuromodulation Devices Market

  • 8.1. Asia-Pacific Internal Neuromodulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Internal Neuromodulation Devices Market

  • 9.1. China Internal Neuromodulation Devices Market Overview
  • 9.2. China Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Internal Neuromodulation Devices Market

  • 10.1. India Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Internal Neuromodulation Devices Market

  • 11.1. Japan Internal Neuromodulation Devices Market Overview
  • 11.2. Japan Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Internal Neuromodulation Devices Market

  • 12.1. Australia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Internal Neuromodulation Devices Market

  • 13.1. Indonesia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Internal Neuromodulation Devices Market

  • 14.1. South Korea Internal Neuromodulation Devices Market Overview
  • 14.2. South Korea Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Internal Neuromodulation Devices Market

  • 15.1. Western Europe Internal Neuromodulation Devices Market Overview
  • 15.2. Western Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Internal Neuromodulation Devices Market

  • 16.1. UK Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Internal Neuromodulation Devices Market

  • 17.1. Germany Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Internal Neuromodulation Devices Market

  • 18.1. France Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Internal Neuromodulation Devices Market

  • 19.1. Italy Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Internal Neuromodulation Devices Market

  • 20.1. Spain Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Internal Neuromodulation Devices Market

  • 21.1. Eastern Europe Internal Neuromodulation Devices Market Overview
  • 21.2. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Internal Neuromodulation Devices Market

  • 22.1. Russia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Internal Neuromodulation Devices Market

  • 23.1. North America Internal Neuromodulation Devices Market Overview
  • 23.2. North America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Internal Neuromodulation Devices Market

  • 24.1. USA Internal Neuromodulation Devices Market Overview
  • 24.2. USA Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Internal Neuromodulation Devices Market

  • 25.1. Canada Internal Neuromodulation Devices Market Overview
  • 25.2. Canada Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Internal Neuromodulation Devices Market

  • 26.1. South America Internal Neuromodulation Devices Market Overview
  • 26.2. South America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Internal Neuromodulation Devices Market

  • 27.1. Brazil Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Internal Neuromodulation Devices Market

  • 28.1. Middle East Internal Neuromodulation Devices Market Overview
  • 28.2. Middle East Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Internal Neuromodulation Devices Market

  • 29.1. Africa Internal Neuromodulation Devices Market Overview
  • 29.2. Africa Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Internal Neuromodulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Internal Neuromodulation Devices Market Competitive Landscape
  • 30.2. Internal Neuromodulation Devices Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. BioControl Medical Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Aleva Neurotherapeutics SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bioness Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Internal Neuromodulation Devices Market Other Major And Innovative Companies

  • 31.1. Uroplasty Inc.
  • 31.2. Abbott Laboratories
  • 31.3. EnteroMedics Inc.
  • 31.4. LivaNova plc
  • 31.5. NeuroPace Inc.
  • 31.6. Synapse Biomedical Inc.
  • 31.7. Soterix Medical Inc.
  • 31.8. Neuros Medical Inc.
  • 31.9. Nevro Corp.
  • 31.10. Nuvectra Corporation
  • 31.11. Stimwave Technologies Incorporated
  • 31.12. SPR Therapeutics
  • 31.13. Axonics Modulation Technologies Inc.
  • 31.14. Saluda Medical Pty Limited
  • 31.15. MicroTransponder Inc.

32. Global Internal Neuromodulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Internal Neuromodulation Devices Market

34. Recent Developments In The Internal Neuromodulation Devices Market

35. Internal Neuromodulation Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Internal Neuromodulation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Internal Neuromodulation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Internal Neuromodulation Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer